Back to Search
Start Over
SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy.
- Source :
-
Haematologica [Haematologica] 2021 Feb 01; Vol. 106 (2), pp. 619-621. Date of Electronic Publication: 2021 Feb 01. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 106
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Report
- Accession number :
- 32299904
- Full Text :
- https://doi.org/10.3324/haematol.2020.249276